STAT on Nostr: The FDA approved a new treatment for primary biliary cholangitis, an autoimmune liver ...

The FDA approved a new treatment for primary biliary cholangitis, an autoimmune liver disease mainly affecting women that causes decreased liver function, debilitating itching, and fatigue.

https://www.statnews.com/2024/08/14/gilead-sciences-livdelzi-primary-biliary-cholangitis/?utm_medium=social&utm_source=mastodon&utm_campaign=mastodon_organic